Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2008
06/25/2008CN101204585A Method of building animal model for parkinsonism
06/25/2008CN101204584A Tumor vaccine using salmonella as carrier and preparation method thereof
06/25/2008CN101204583A Application of PDCD4 regroup expression vector on process for preparing medicine curing glioma
06/25/2008CN101204582A Hepatitis B fusion protein multiva lentvaccine, preparation method and uses thereof
06/25/2008CN101204404A RA preventing and curing for piglet yellow scour, preparation and application thereof
06/25/2008CN100397082C HCV-free-blood external preparing method
06/25/2008CN100397081C Diagnosing tumorigenicity and determining resistance to the antineoplastic therapy
06/25/2008CN100397078C Method for identifying substances
06/25/2008CN100396793C Brassica campestris ssp. Chinensis cytoplasmic male sterile gene molecular marking method
06/25/2008CN100396789C Apparatus for polynucleotide detection and quantitation
06/25/2008CN100396788C Multiplex oligonucleotide addition and target amplification
06/25/2008CN100396784C Methods of inducing the expression of bone morphogenetic proteins (BMPs) and transforming growth factor-beta-proteins (TGF-ª‰s) in cells
06/25/2008CN100396778C Construction method of secretory coenosarcus plasmid for bombyx mori rhabditis viral expression system
06/25/2008CN100396777C Thermophilic alkali alpha amylase and its coding gene
06/25/2008CN100396776C Method for breeding anti-disease wheat and its special gene
06/25/2008CN100396775C PCR method of universal primer and its reaction liquid and application in multiple PCR
06/25/2008CN100396701C Fusion protein of extrasin alpha1 and interferon
06/25/2008CN100396700C Recombinant fusion protein of mycobacterium tuberculosis Ag85B antigen and human IL-2, and its uses
06/25/2008CN100396699C Transgenic mammal carrying GANP gene transferred thereinto and utilization thereof
06/25/2008CN100396698C New mastocancer related protein and its specificity multiclone antibody
06/25/2008CN100396697C New mastocancer related protein and its specificity multiclone antibody
06/24/2008US7392233 Image searching system, image searching method, and a recording medium storing an image searching program
06/24/2008US7392141 Polypeptides; genetic engineering
06/24/2008US7390945 Plants and seeds of corn variety I291859
06/24/2008US7390942 Soybean variety 0385457
06/24/2008US7390941 Soybean variety 4735316
06/24/2008US7390940 Soybean variety 4858197
06/24/2008US7390939 Soybean variety 4092390
06/24/2008US7390938 Soybean variety 4735486
06/24/2008US7390937 Plants with enhanced levels of nitrogen utilization proteins in their root epidermis and uses thereof
06/24/2008US7390936 Commercial production of chymosin in plants
06/24/2008US7390895 Rapamycin analogues; diabetes, acute or chronic rejection of an organ or tissue transplant, asthma, tumours, psoriasis, eczema, rheumatoid arthritis, fibrosis, and allergies
06/24/2008US7390894 Glutathione S-transferase sequence variants
06/24/2008US7390893 Sequence-determined DNA fragments encoding peptide transport proteins
06/24/2008US7390892 nucleotide sequences and genes that code for proteins as well as antibodies raised against such proteins; enzymes used in screening assays to identify antiprotozoa agents; antibodies use to protect animals from disease caused by parasites
06/24/2008US7390891 Affect aging and/or proliferation of cells in the human
06/24/2008US7390888 Dendritic cell potentiation
06/24/2008US7390887 Antibodies against PRO4330
06/24/2008US7390886 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders
06/24/2008US7390885 Humanized collagen antibodies and related methods
06/24/2008US7390883 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by skeletal cells/adipocytes; for stimulating the release of proteoglycans from cartilage
06/24/2008US7390882 Compositions and methods for the diagnosis and treatment of tumor
06/24/2008US7390881 first component is the modified antigenic ectodomain of measles virus hemagglutinin protein, second component fused to first component that binds a surface protein of human immunodeficiency virus; for treating HIV infection and other therapeutic targets against which it is difficult to develop vaccines
06/24/2008US7390880 Soluble interleukin-1 receptor accessory molecule
06/24/2008US7390878 PRO6090 polypeptides
06/24/2008US7390877 Vectors with DNA encoding pro polypeptides
06/24/2008US7390873 Microbiocides; bactericides
06/24/2008US7390872 fusion proteins has high transduction potential, inhibits the NF- kappa B pathway; biodrugs as antiinflammatory agents, viricides, antiproliferative agents, immunostimulants
06/24/2008US7390792 Method of reducing Delta protein expression in a cell comprising the steps of introducing into the cell miR-1 and detecting a resultant reduction of Delta protein expression in the cell; resultant reduction is quantitatively detected
06/24/2008US7390787 Comprising 8 to 25 amino acids and containing the formula: RXZXXZXB wherein Z is proline or valine; X is a hydrophobic residue; and B is a basic amino acid.
06/24/2008US7390785 Amino acid sequences; from venom of snails; analgesics
06/24/2008US7390781 Methods of using truncated glial cell line-derived neurotrophic factor
06/24/2008US7390780 For transfecting nucleic acids in vivo or ex vivo; vesicle forming lipid and hydrophilic polymer; gene therapy
06/24/2008US7390661 Transcription activation module comprising nucleotide sequence; vectors for genetic engineering in plants
06/24/2008US7390657 Method for generating primate trophoblasts
06/24/2008US7390655 Promoter molecules for use in plants
06/24/2008US7390654 Avoidance of undesirable replication intermediates in plasmid propagation
06/24/2008US7390652 Bioreactor comprising device for separating cells from microcarriers; viral particle generation
06/24/2008US7390648 Cell labeling, microinjection, intracytoplasmic sperm injection, enucleation; well for holding cell comprising an enucleation penetration emittor operatively connected to a source of electromagnetic signals or vibrational energy; and pit
06/24/2008US7390644 By culturing a Shingomonas bacteria in a fermentation broth for a time and temperature effective for providing a sphingan exopolysaccharide in a slime form
06/24/2008US7390643 Geranyl diphosphate synthase molecules, and nucleic acid molecules encoding same
06/24/2008US7390642 Present invention relates to proteins having salutaridinol 7-O-acetyltransferase activity and to derivatives and analogs of these proteins; use in production of plants having altered alkaloid profiles
06/24/2008US7390640 Circular permutant GFP insertion folding reporters
06/24/2008US7390639 Purified nucleic acid sequence encoding a fusion protein comprising target peptide linked to a fusion carrier protein; carrier protein acts to promote the overexpression of peptide-protein fusion in the form of inclusion bodies, which minimizes in-cell proteolysis of peptides; nuclear magnetic resonance
06/24/2008US7390638 A polynucleotide encoding a carboxy-truncated interferon gamma (IFNG) polypeptide mutant exhibiting IFNG receptor binding activity having the amino acid sequence, SEQ ID NO:12, or 1-10 residue modifications; antitumor, -carcinogenic agent; viricides; interstitial lung diseases; autoimmune diseases
06/24/2008US7390637 Keratinocyte derived interferon
06/24/2008US7390636 Method for construction and use of Kluyveromyces lactis promoter variants in K. lactis that substantially lack E. coli transcriptional capability
06/24/2008US7390635 selected from heavy chains, light chains and modified variable regions; breast cancer therapy; detecting using antigen and antibody complex; immunoassay, immunotherapy
06/24/2008US7390634 Useful in treating ovarian, renal, neurological, cardiovascular disorders and modulating angiogenesis, cell proliferation
06/24/2008US7390633 Methods for preparing low molecular weight heparin with modified heparinase III
06/24/2008US7390632 Soluble ErbB3 receptor isoforms
06/24/2008US7390630 Method of identifying a compound that selectively inhibits cytokine-stimulated T cell induced production of TNF-alpha by monocytes
06/24/2008US7390623 Detection and identification of staphylococcus aureus and epidermidis using the 16S-23S rRNA spacer
06/24/2008US7390619 Creating a library of mutant polynucleotides from at least two nucleic acids encoding a B7-1 (CD80) protein; expressing in cells and screening for the optimized polynucleotide; increased T-cell response, increased activity through CD28 and a decreased activity through CTLA-4
06/24/2008US7390494 Vaccine comprises nucleic acid encodes an immunogenic protein that induces a protective response effective against infection by a piglet weight loss disease circovirus; structural and non-structural polypeptides, vectors, and cells transformed by the vectors; kits for diagnosing
06/24/2008US7390486 PRO4381 antibodies
06/24/2008US7390485 Genetically engineered soluble form of CD39L3 or fusion protein of soluble form with heterologous sequence; deletions and replacements; anticoagulant, antiinflammatory, antihypoxic, and antiischemic agents; atherosclerosis, arteriosclerosis, preeclampsia, strokes; cardiovascular disorders
06/24/2008US7390483 Modified by introduction of nucleic acid molecule comprising a nucleic acid sequence encoding granulocyte macrophage-colony stimulating factor (GM-CSF) operably linked to a promoter; contains cancer antigen; immunotherapy
06/24/2008US7390481 Mammalian cytokine complexes
06/24/2008US7390458 Provides flexibility, robustness, accuracy
06/19/2008WO2008074025A2 Novel genes and rna molecules that confer stress tolerance
06/19/2008WO2008073959A2 Synthetic agonists of tlr9
06/19/2008WO2008073923A2 Mirna regulated genes and pathways as targets for therapeutic intervention
06/19/2008WO2008073922A2 Functions and targets of let-7 micro rnas
06/19/2008WO2008073921A2 Mir-126 regulated genes and pathways as targets for therapeutic intervention
06/19/2008WO2008073920A2 Mir-21 regulated genes and pathways as targets for therapeutic intervention
06/19/2008WO2008073919A2 Mir-20 regulated genes and pathways as targets for therapeutic intervention
06/19/2008WO2008073877A2 Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof
06/19/2008WO2008073800A2 Acetolactate synthase herbicide resistant sorghum
06/19/2008WO2008073688A2 Improved expression system for recombinant human arginase i
06/19/2008WO2008073661A2 Long term disease modification using immunostimulatory oligonucleotides
06/19/2008WO2008073578A2 Plant genes involved in nitrate uptake and metabolism
06/19/2008WO2008073479A2 Anticonnexin polynucleotides as impaired wound healing compositions
06/19/2008WO2008073406A2 Solvent tolerant microorganisms
06/19/2008WO2008073275A2 Mutant delta-8 desaturase genes engineered by targeted mutagensis and their use in making polyunsaturated fatty acids
06/19/2008WO2008072921A1 Enhanced butanol producing microorganisms and method for preparing butanol using the same
06/19/2008WO2008072895A1 Cell surface expression vector for liver cancer specific antigen alpha-fetoprotein and microorganism transformed by thereof
06/19/2008WO2008072781A1 Method for prevention or treatment of memory disorder in mammal
06/19/2008WO2008072741A1 Cancer test method, cancer test kit, and cancer test agent
06/19/2008WO2008072723A1 ANTI-Claudin-3 MONOCLONAL ANTIBODY, AND TREATMENT AND DIAGNOSIS OF CANCER USING THE SAME